Search for: "Par Pharmaceutical"
Results 81 - 100
of 303
Sorted by Relevance
|
Sort by Date
19 Oct 2012, 6:13 pm
The majority of the assets in these 18 markets would be divested to Par Pharmaceutical, Inc. [read post]
19 Aug 2022, 11:15 am
This week in Other Barks & Bites: the Federal Circuit rules that Eagle Pharmaceutical’s ANDA defines a product that does not infringe upon Par Pharmaceutical’s patents covering Vasostrict; an inventor amicus brief in the OpenSky IPR asks USPTO Director Vidal to mandate sanctions for abuse of PTAB process; the Seventh Circuit affirms a default judgment against a Chinese counterfeiter of sports merchandise after finding personal jurisdiction over the… [read post]
19 Aug 2022, 11:15 am
This week in Other Barks & Bites: the Federal Circuit rules that Eagle Pharmaceutical’s ANDA defines a product that does not infringe upon Par Pharmaceutical’s patents covering Vasostrict; an inventor amicus brief in the OpenSky IPR asks USPTO Director Vidal to mandate sanctions for abuse of PTAB process; the Seventh Circuit affirms a default judgment against a Chinese counterfeiter of sports merchandise after finding personal jurisdiction over the… [read post]
24 Oct 2017, 4:15 am
See Par Pharmaceutical, Inc. v. [read post]
26 Jan 2016, 11:23 am
**As one small footnote, Ampyra is not a disease-modifying treatment for MS, in contrast to Copaxone or Tecfidera.link to BNA report: http://www.bna.com/acorda-par-settle-n57982066522/ [read post]
25 Mar 2015, 4:42 am
Mar. 17, 2015) Par’s vasopressin injection product, Vasostrict, is a FDA-approved pharmaceutical. [read post]
12 Jun 2011, 9:17 pm
.; Par Pharmaceutical Inc. [read post]
19 Apr 2018, 12:00 am
Endo acquired Par Pharmaceuticals (“Par”) in 2015. [read post]
15 Apr 2019, 7:19 pm
Par Pharmaceutical Inc., Nos. 14-1289-RGA, 14-1494-RGA, 15-0078-RGA (D. [read post]
18 Oct 2009, 5:42 pm
Judge Brown found that the patent in question, US Patent No. 5,565,473, was valid and enforceable, and [...]...FTC Sues Regarding AndroGel Patent Settlement The Federal Trade Commission has filed a complaint in federal district court challenging agreements in which Solvay Pharmaceuticals, Inc. paid generic drug makers Watson Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. to delay generic competition to Solvay’s branded… [read post]
15 Sep 2011, 5:46 am
Just last month, Florida's attorney general announced an agreement with Par Pharmaceuticals over accusations it inflated prices for medications billed to Medicaid. [read post]
26 Apr 2017, 7:24 am
.'" Par Pharmaceutical, Inc. et al v. [read post]
13 Jun 2019, 11:24 am
Facts: This case (Par Pharmaceutical, Inc. et al v. [read post]
9 Sep 2018, 10:25 am
Par Pharmaceutical, Inc. v. [read post]
21 Feb 2016, 8:07 pm
Par Pharmaceutical, Inc. 1:15-cv-00886; filed October 2, 2015 in the District Court of Delaware Infringement of U.S. [read post]
14 Jan 2018, 6:34 am
Novartis Pharmaceuticals Corporation, S233898).Exigences en matière d'étiquetages et notices, ici de médicaments et de dispositifs médicaux Le droit des états, ici californien, protège substantiellement les consommateurs de médicaments des dangers posés par des étiquetages et des notices faux, trompeurs ou inadéquats. [read post]
30 Sep 2013, 8:12 am
.; Mylan Pharmaceuticals, Inc.; Par Pharmaceuticals, Inc.; Ranbaxy Laboratories Ltd.; and related companies and subsidiaries. [read post]
11 Apr 2013, 4:57 am
FTC Sues Regarding AndroGel Patent SettlementThe Federal Trade Commission has filed a complaint in federal district court challenging agreements in which Solvay Pharmaceuticals, Inc. paid generic drug makers Watson Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. to delay generic competition to Solvay’s branded testosterone-replacement drug AndroGel, a prescription pharmaceutical with annual sales of more than $400 million. [read post]
8 Sep 2011, 12:59 pm
Par Pharmaceuticals Under Investigation By U.S. [read post]
10 Oct 2014, 1:16 pm
JHP Pharmaceuticals, LLC v. [read post]
